Zidovudine

齐多夫定

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameZidovudine
Drug Alias Name叠氮胸苷AZTAzidothymidineZidovudinumZidovudina +[11] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHemophilia AKidney DiseasesAIDS Dementia Complex +[5] 
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1987/03/19
Country/TerritoryUnited StatesThailandPuerto Rico +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesViiv Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesGlaxo Operations Uk LtdViiv Healthcare Co
Inactive CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentGlaxo Wellcome IncInstitut De Recherche Pour Le Developpement +[5] 
Active IndicationsHIV Infections
Inactive IndicationsHemophilia AKidney DiseasesAIDS Dementia Complex +[4] 

Other Information

ATC CodeJ05AF01
Related LinksWikipediaDrugBankKEGG